What Changes Under 2025 ASE Diastolic Function Criteria?

• by Kathryn Wighton

• June 26, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

• by Kathryn Wighton

• June 15, 2026

• 3 min

PAHR: Prognostic Marker in Severe Aortic Stenosis?

Researchers evaluated whether a composite measure of heart rate and pressure could capture overall hemodynamic burden.

• by Julia Cipriano, MS, CMPP

• June 27, 2026

• 3 min

GCS May Expand CTRCD Assessment

Award-winning ASE abstract highlights GCS when GLS assessment is limited by suboptimal apical windows.

• by Julia Cipriano, MS, CMPP

• June 29, 2026

• 4 min